Smartphone-Based Screening for Cardiovascular Diseases: A Trend?

Abstract Cardiovascular diseases are the leading cause of death in the world. People living in vulnerable and poor places such as slums, rural areas and remote locations have difficulty in accessing medical care and diagnostic tests. In addition, given the COVID-19 pandemic, we are witnessing an increase in the use of telemedicine and non-invasive tools for monitoring vital signs. These questions motivate us to write this point of view and to describe some of the main innovations used for non-invasive screening of heart diseases. Smartphones are widely used by the population and are perfect tools for screening cardiovascular diseases. They are equipped with camera, flashlight, microphone, processor, and internet connection, which allow optical, electrical, and acoustic analysis of cardiovascular phenomena. Thus, when using signal processing and artificial intelligence approaches, smartphones may have predictive power for cardiovascular diseases. Here we present different smartphone approaches to analyze signals obtained from various methods including photoplethysmography, phonocardiograph, and electrocardiography to estimate heart rate, blood pressure, oxygen saturation (SpO2), heart murmurs and electrical conduction. Our objective is to present innovations in non-invasive diagnostics using the smartphone and to reflect on these trending approaches. These could help to improve health access and the screening of cardiovascular diseases for millions of people, particularly those living in needy areas.

AAPM task group report 273: Recommendations on best practices for AI and machine learning for computer-aided diagnosis in medical imaging.

Rapid advances in artificial intelligence (AI) and machine learning, and specifically in deep learning (DL) techniques, have enabled broad application of these methods in health care. The promise of the DL approach has spurred further interest in computer-aided diagnosis (CAD) development and applications using both "traditional" machine learning methods and newer DL-based methods. We use the term CAD-AI to refer to this expanded clinical decision support environment that uses traditional and DL-based AI methods. Numerous studies have been published to date on the development of machine learning tools for computer-aided, or AI-assisted, clinical tasks. However, most of these machine learning models are not ready for clinical deployment. It is of paramount importance to ensure that a clinical decision support tool undergoes proper training and rigorous validation of its generalizability and robustness before adoption for patient care in the clinic. To address these important issues, the American Association of Physicists in Medicine (AAPM) Computer-Aided Image Analysis Subcommittee (CADSC) is charged, in part, to develop recommendations on practices and standards for the development and performance assessment of computer-aided decision support systems. The committee has previously published two opinion papers on the evaluation of CAD systems and issues associated with user training and quality assurance of these systems in the clinic. With machine learning techniques continuing to evolve and CAD applications expanding to new stages of the patient care process, the current task group report considers the broader issues common to the development of most, if not all, CAD-AI applications and their translation from the bench to the clinic. The goal is to bring attention to the proper training and validation of machine learning algorithms that may improve their generalizability and reliability and accelerate the adoption of CAD-AI systems for clinical decision support.

TOPSIS aided ensemble of CNN models for screening COVID-19 in chest X-ray images.

The novel coronavirus (COVID-19), has undoubtedly imprinted our lives with its deadly impact. Early testing with isolation of the individual is the best possible way to curb the spread of this deadly virus. Computer aided diagnosis (CAD) provides an alternative and cheap option for screening of the said virus. In this paper, we propose a convolution neural network (CNN)-based CAD method for COVID-19 and pneumonia detection from chest X-ray images. We consider three input types for three identical base classifiers. To capture maximum possible complementary features, we consider the original RGB image, Red channel image and the original image stacked with Robert's edge information. After that we develop an ensemble strategy based on the technique for order preference by similarity to an ideal solution (TOPSIS) to aggregate the outcomes of base classifiers. The overall framework, called TOPCONet, is very light in comparison with standard CNN models in terms of the number of trainable parameters required. TOPCONet achieves state-of-the-art results when evaluated on the three publicly available datasets: (1) IEEE COVID-19 dataset + Kaggle Pneumonia Dataset, (2) Kaggle Radiography dataset and (3) COVIDx.

Integrating patient symptoms, clinical readings, and radiologist feedback with computer-aided diagnosis system for detection of infectious pulmonary disease: a feasibility study.

Automatic computer-aided diagnosis (CAD) system has been widely used as an assisting tool for mass screening and risk assessment of infectious pulmonary diseases (PDs). However, such a system still lacks clinical acceptability and trust due to the integration gap between the patient's metadata, radiologist feedback, and the CAD system. This paper proposed three integration frameworks, namely-direct integration (DI), rule-based integration (RBI), and weight-based integration (WBI). The proposed framework helps clinicians diagnose lung inflammation and provide an end-to-end robust diagnostic system. Initially, the feasibility of integrating patients' symptoms, clinical pathologies, and radiologist feedback with CAD system to improve the classification performance is investigated. Subsequently, the patient's metadata and radiologist feedback are integrated with the CAD system using the proposed integration frameworks. The proposed method's performance is evaluated using a private dataset consisting of 70 chest X-ray (CXR) images (31 COVID-19, 14 other diseases, and 25 normal). The obtained results reveal that the proposed WBI achieved the highest classification performance (accuracy = 98.18%, F1 score = 97.73%, and Matthew's correlation coefficient = 0.969) compared to DI and RI. The generalization capability of the proposed framework is also verified from an external validation set. Furthermore, the Friedman average ranking and Shaffer and Holm post hoc statistical methods reveal the obtained results' statistical significance. Methodological diagram of proposed integration frameworks.

Disease Localization and Severity Assessment in Chest X-Ray Images using Multi-Stage Superpixels Classification.

BACKGROUND AND OBJECTIVES: Chest X-ray (CXR) is a non-invasive imaging modality used in the prognosis and management of chronic lung disorders like tuberculosis (TB), pneumonia, coronavirus disease (COVID-19), etc. The radiomic features associated with different disease manifestations assist in detection, localization, and grading the severity of infected lung regions. The majority of the existing computer-aided diagnosis (CAD) system used these features for the classification task, and only a few works have been dedicated to disease-localization and severity scoring. Moreover, the existing deep learning approaches use class activation map and Saliency map, which generate a rough localization. This study aims to generate a compact disease boundary, infection map, and grade the infection severity using proposed multistage superpixel classification-based disease localization and severity assessment framework. METHODS: The proposed method uses a simple linear iterative clustering (SLIC) technique to subdivide the lung field into small superpixels. Initially, the different radiomic texture and proposed shape features are extracted and combined to train different benchmark classifiers in a multistage framework. Subsequently, the predicted class labels are used to generate an infection map, mark disease boundary, and grade the infection severity. The performance is evaluated using a publicly available Montgomery dataset and validated using Friedman average ranking and Holm and Nemenyi post-hoc procedures. RESULTS: The proposed multistage classification approach achieved accuracy (ACC)= 95.52%, F-Measure (FM)= 95.48%, area under the curve (AUC)= 0.955 for Stage-I and ACC=85.35%, FM=85.20%, AUC=0.853 for Stage-II using calibration dataset and ACC = 93.41%, FM = 95.32%, AUC = 0.936 for Stage-I and ACC = 84.02%, FM = 71.01%, AUC = 0.795 for Stage-II using validation dataset. Also, the model has demonstrated the average Jaccard Index (JI) of 0.82 and Pearson's correlation coefficient (r) of 0.9589. CONCLUSIONS: The obtained classification results using calibration and validation dataset confirms the promising performance of the proposed framework. Also, the average JI shows promising potential to localize the disease, and better agreement between radiologist score and predicted severity score (r) confirms the robustness of the method. Finally, the statistical test justified the significance of the obtained results.

Intelligent Diagnosis Method for New Diseases Based on Fuzzy SVM Incremental Learning.

The diagnosis of new diseases is a challenging problem. In the early stage of the emergence of new diseases, there are few case samples; this may lead to the low accuracy of intelligent diagnosis. Because of the advantages of support vector machine (SVM) in dealing with small sample problems, it is selected for the intelligent diagnosis method. The standard SVM diagnosis model updating needs to retrain all samples. It costs huge storage and calculation costs and is difficult to adapt to the changing reality. In order to solve this problem, this paper proposes a new disease diagnosis method based on Fuzzy SVM incremental learning. According to SVM theory, the support vector set and boundary sample set related to the SVM diagnosis model are extracted. Only these sample sets are considered in incremental learning to ensure the accuracy and reduce the cost of calculation and storage. To reduce the impact of noise points caused by the reduction of training samples, FSVM is used to update the diagnosis model, and the generalization is improved. The simulation results on the banana dataset show that the proposed method can improve the classification accuracy from 86.4% to 90.4%. Finally, the method is applied in COVID-19's diagnostic. The diagnostic accuracy reaches 98.2% as the traditional SVM only gets 84%. With the increase of the number of case samples, the model is updated. When the training samples increase to 400, the number of samples participating in training is only 77; the amount of calculation of the updated model is small.

Efficacy of virtual and asynchronous teaching of computer-assisted diagnosis of genetic diseases seen in clinics.

We studied if clinicians could gain sufficient working knowledge of a computer-assisted diagnostic decision support system (DDSS) (SimulConsult), to make differential diagnoses (DDx) of genetic disorders. We hypothesized that virtual training could be convenient, asynchronous, and effective in teaching clinicians how to use a DDSS. We determined the efficacy of virtual, asynchronous teaching for clinicians to gain working knowledge to make computer-assisted DDx. Our study consisted of three surveys (Baseline, Training, and After Use) and a series of case problems sent to clinicians at Vanderbilt University Medical Center. All participants were able to generate computer-assisted DDx that achieved passing scores of the case problems. Between 75% and 92% agreed/completely agreed the DDSS was useful to their work and for clinical decision support and was easy to use. Participants' use of the DDSS resulted in statistically significant time savings in key tasks and in total time spent on clinical tasks. Our results indicate that virtual, asynchronous teaching can be an effective format to gain a working knowledge of a DDSS, and its clinical use could result in significant time savings across multiple tasks as well as facilitate synergistic interaction between clinicians and lab specialists. This approach is especially pertinent and offers value amid the COVID-19 pandemic.

GACDN: generative adversarial feature completion and diagnosis network for COVID-19.

BACKGROUND: The outbreak of coronavirus disease 2019 (COVID-19) causes tens of million infection world-wide. Many machine learning methods have been proposed for the computer-aided diagnosis between COVID-19 and community-acquired pneumonia (CAP) from chest computed tomography (CT) images. Most of these methods utilized the location-specific handcrafted features based on the segmentation results to improve the diagnose performance. However, the prerequisite segmentation step is time-consuming and needs the intervention by lots of expert radiologists, which cannot be achieved in the areas with limited medical resources. METHODS: We propose a generative adversarial feature completion and diagnosis network (GACDN) that simultaneously generates handcrafted features by radiomic counterparts and makes accurate diagnoses based on both original and generated features. Specifically, we first calculate the radiomic features from the CT images. Then, in order to fast obtain the location-specific handcrafted features, we use the proposed GACDN to generate them by its corresponding radiomic features. Finally, we use both radiomic features and location-specific handcrafted features for COVID-19 diagnosis. RESULTS: For the performance of our generated location-specific handcrafted features, the results of four basic classifiers show that it has an average of 3.21% increase in diagnoses accuracy. Besides, the experimental results on COVID-19 dataset show that our proposed method achieved superior performance in COVID-19 vs. community acquired pneumonia (CAP) classification compared with the state-of-the-art methods. CONCLUSIONS: The proposed method significantly improves the diagnoses accuracy of COVID-19 vs. CAP in the condition of incomplete location-specific handcrafted features. Besides, it is also applicable in some regions lacking of expert radiologists and high-performance computing resources.

Accuracy of deep learning-based computed tomography diagnostic system for COVID-19: A consecutive sampling external validation cohort study.

Ali-M3, an artificial intelligence program, analyzes chest computed tomography (CT) and detects the likelihood of coronavirus disease (COVID-19) based on scores ranging from 0 to 1. However, Ali-M3 has not been externally validated. Our aim was to evaluate the accuracy of Ali-M3 for detecting COVID-19 and discuss its clinical value. We evaluated the external validity of Ali-M3 using sequential Japanese sampling data. In this retrospective cohort study, COVID-19 infection probabilities for 617 symptomatic patients were determined using Ali-M3. In 11 Japanese tertiary care facilities, these patients underwent reverse transcription-polymerase chain reaction (RT-PCR) testing. They also underwent chest CT to confirm a diagnosis of COVID-19. Of the 617 patients, 289 (46.8%) were RT-PCR-positive. The area under the curve (AUC) of Ali-M3 for predicting a COVID-19 diagnosis was 0.797 (95% confidence interval: 0.762‒0.833) and the goodness-of-fit was P = 0.156. With a cut-off probability of a diagnosis of COVID-19 by Ali-M3 set at 0.5, the sensitivity and specificity were 80.6% and 68.3%, respectively. A cut-off of 0.2 yielded a sensitivity and specificity of 89.2% and 43.2%, respectively. Among the 223 patients who required oxygen, the AUC was 0.825. Sensitivity at a cut-off of 0.5% and 0.2% was 88.7% and 97.9%, respectively. Although the sensitivity was lower when the days from symptom onset were fewer, the sensitivity increased for both cut-off values after 5 days. We evaluated Ali-M3 using external validation with symptomatic patient data from Japanese tertiary care facilities. As Ali-M3 showed sufficient sensitivity performance, despite a lower specificity performance, Ali-M3 could be useful in excluding a diagnosis of COVID-19.

Automated Diagnosis of Chest X-Ray for Early Detection of COVID-19 Disease.

In March 2020, the World Health Organization announced the COVID-19 pandemic, its dangers, and its rapid spread throughout the world. In March 2021, the second wave of the pandemic began with a new strain of COVID-19, which was more dangerous for some countries, including India, recording 400,000 new cases daily and more than 4,000 deaths per day. This pandemic has overloaded the medical sector, especially radiology. Deep-learning techniques have been used to reduce the burden on hospitals and assist physicians for accurate diagnoses. In our study, two models of deep learning, ResNet-50 and AlexNet, were introduced to diagnose X-ray datasets collected from many sources. Each network diagnosed a multiclass (four classes) and a two-class dataset. The images were processed to remove noise, and a data augmentation technique was applied to the minority classes to create a balance between the classes. The features extracted by convolutional neural network (CNN) models were combined with traditional Gray-level Cooccurrence Matrix (GLCM) and Local Binary Pattern (LBP) algorithms in a 1-D vector of each image, which produced more representative features for each disease. Network parameters were tuned for optimum performance. The ResNet-50 network reached accuracy, sensitivity, specificity, and Area Under the Curve (AUC) of 95%, 94.5%, 98%, and 97.10%, respectively, with the multiclasses (COVID-19, viral pneumonia, lung opacity, and normal), while it reached accuracy, sensitivity, specificity, and AUC of 99%, 98%, 98%, and 97.51%, respectively, with the binary classes (COVID-19 and normal).

COVID-19 Diagnosis Using Capsule Network and Fuzzy C-Means and Mayfly Optimization Algorithm.

The COVID-19 epidemic is spreading day by day. Early diagnosis of this disease is essential to provide effective preventive and therapeutic measures. This process can be used by a computer-aided methodology to improve accuracy. In this study, a new and optimal method has been utilized for the diagnosis of COVID-19. Here, a method based on fuzzy C-ordered means (FCOM) along with an improved version of the enhanced capsule network (ECN) has been proposed for this purpose. The proposed ECN method is improved based on mayfly optimization (MFO) algorithm. The suggested technique is then implemented on the chest X-ray COVID-19 images from publicly available datasets. Simulation results are assessed by considering a comparison with some state-of-the-art methods, including FOMPA, MID, and 4S-DT. The results show that the proposed method with 97.08% accuracy and 97.29% precision provides the highest accuracy and reliability compared with the other studied methods. Moreover, the results show that the proposed method with a 97.1% sensitivity rate has the highest ratio. And finally, the proposed method with a 97.47% F1-score rate gives the uppermost value compared to the others.

Artificial Intelligence Predicts Severity of COVID-19 Based on Correlation of Exaggerated Monocyte Activation, Excessive Organ Damage and Hyperinflammatory Syndrome: A Prospective Clinical Study.

Background: Prediction of the severity of COVID-19 at its onset is important for providing adequate and timely management to reduce mortality. Objective: To study the prognostic value of damage parameters and cytokines as predictors of severity of COVID-19 using an extensive immunologic profiling and unbiased artificial intelligence methods. Methods: Sixty hospitalized COVID-19 patients (30 moderate and 30 severe) and 17 healthy controls were included in the study. The damage indicators high mobility group box 1 (HMGB1), lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), extensive biochemical analyses, a panel of 47 cytokines and chemokines were analyzed at weeks 1, 2 and 7 along with clinical complaints and CT scans of the lungs. Unbiased artificial intelligence (AI) methods (logistic regression and Support Vector Machine and Random Forest algorithms) were applied to investigate the contribution of each parameter to prediction of the severity of the disease. Results: On admission, the severely ill patients had significantly higher levels of LDH, IL-6, monokine induced by gamma interferon (MIG), D-dimer, fibrinogen, glucose than the patients with moderate disease. The levels of macrophage derived cytokine (MDC) were lower in severely ill patients. Based on artificial intelligence analysis, eight parameters (creatinine, glucose, monocyte number, fibrinogen, MDC, MIG, C-reactive protein (CRP) and IL-6 have been identified that could predict with an accuracy of 83-87% whether the patient will develop severe disease. Conclusion: This study identifies the prognostic factors and provides a methodology for making prediction for COVID-19 patients based on widely accepted biomarkers that can be measured in most conventional clinical laboratories worldwide.

A Simple Clinical Prediction Tool for COVID-19 in Primary Care with Epidemiology: Temperature-Leukocytes-CT Results.

BACKGROUND Effective identification of patients with suspected COVID-19 is vital for the management. This study aimed to establish a simple clinical prediction model for COVID-19 in primary care. MATERIAL AND METHODS We consecutively enrolled 60 confirmed cases and 152 suspected cases with COVID-19 into the study. The training cohort consisted of 30 confirmed and 78 suspected cases, whereas the validation cohort consisted of 30 confirmed and 74 suspected cases. Four clinical variables - epidemiological history (E), body temperature (T), leukocytes count (L), and chest computed tomography (C) - were collected to construct a preliminary prediction model (model A). By integerizing coefficients of model A, a clinical prediction model (model B) was constructed. Finally, the scores of each variable in model B were summed up to build the ETLC score. RESULTS The preliminary prediction model A was Logit (YA)=2.657X1+1.153X2+2.125X3+2.828X4-10.771, while the model B was Logit (YB)=2.5X1+1X2+2X3+3X4-10. No significant difference was found between the area under the curve (AUC) of model A (0.920, 95% CI: 0.875-0.953) and model B (0.919, 95% CI: 0.874-0.952) (Z=0.035, P=0.972). When ETLC score was more than or equal to 9.5, the sensitivity and specificity for COVID-19 was 76.7% (46/60) and 90.1% (137/152), respectively, and the positive and negative predictive values were 75.4% (46/61) and 90.7% (137/151), respectively. CONCLUSIONS The ETLC score is helpful for efficiently identifying patients with suspected COVID-19.

Combining a convolutional neural network with autoencoders to predict the survival chance of COVID-19 patients.

COVID-19 has caused many deaths worldwide. The automation of the diagnosis of this virus is highly desired. Convolutional neural networks (CNNs) have shown outstanding classification performance on image datasets. To date, it appears that COVID computer-aided diagnosis systems based on CNNs and clinical information have not yet been analysed or explored. We propose a novel method, named the CNN-AE, to predict the survival chance of COVID-19 patients using a CNN trained with clinical information. Notably, the required resources to prepare CT images are expensive and limited compared to those required to collect clinical data, such as blood pressure, liver disease, etc. We evaluated our method using a publicly available clinical dataset that we collected. The dataset properties were carefully analysed to extract important features and compute the correlations of features. A data augmentation procedure based on autoencoders (AEs) was proposed to balance the dataset. The experimental results revealed that the average accuracy of the CNN-AE (96.05%) was higher than that of the CNN (92.49%). To demonstrate the generality of our augmentation method, we trained some existing mortality risk prediction methods on our dataset (with and without data augmentation) and compared their performances. We also evaluated our method using another dataset for further generality verification. To show that clinical data can be used for COVID-19 survival chance prediction, the CNN-AE was compared with multiple pre-trained deep models that were tuned based on CT images.

Developing a Recognition System for Diagnosing Melanoma Skin Lesions Using Artificial Intelligence Algorithms.

In recent years, computerized biomedical imaging and analysis have become extremely promising, more interesting, and highly beneficial. They provide remarkable information in the diagnoses of skin lesions. There have been developments in modern diagnostic systems that can help detect melanoma in its early stages to save the lives of many people. There is also a significant growth in the design of computer-aided diagnosis (CAD) systems using advanced artificial intelligence. The purpose of the present research is to develop a system to diagnose skin cancer, one that will lead to a high level of detection of the skin cancer. The proposed system was developed using deep learning and traditional artificial intelligence machine learning algorithms. The dermoscopy images were collected from the PH2 and ISIC 2018 in order to examine the diagnose system. The developed system is divided into feature-based and deep leaning. The feature-based system was developed based on feature-extracting methods. In order to segment the lesion from dermoscopy images, the active contour method was proposed. These skin lesions were processed using hybrid feature extractions, namely, the Local Binary Pattern (LBP) and Gray Level Co-occurrence Matrix (GLCM) methods to extract the texture features. The obtained features were then processed using the artificial neural network (ANNs) algorithm. In the second system, the convolutional neural network (CNNs) algorithm was applied for the efficient classification of skin diseases; the CNNs were pretrained using large AlexNet and ResNet50 transfer learning models. The experimental results show that the proposed method outperformed the state-of-art methods for HP2 and ISIC 2018 datasets. Standard evaluation metrics like accuracy, specificity, sensitivity, precision, recall, and F-score were employed to evaluate the results of the two proposed systems. The ANN model achieved the highest accuracy for PH2 (97.50%) and ISIC 2018 (98.35%) compared with the CNN model. The evaluation and comparison, proposed systems for classification and detection of melanoma are presented.

Study on the prognosis predictive model of COVID-19 patients based on CT radiomics.

Making timely assessments of disease progression in patients with COVID-19 could help offer the best personalized treatment. The purpose of this study was to explore an effective model to predict the outcome of patients with COVID-19. We retrospectively included 188 patients (124 in the training set and 64 in the test set) diagnosed with COVID-19. Patients were divided into aggravation and improvement groups according to the disease progression. Three kinds of models were established, including the radiomics, clinical, and combined model. Receiver operating characteristic curves, decision curves, and Delong's test were used to evaluate and compare the models. Our analysis showed that all the established prediction models had good predictive performance in predicting the progress and outcome of COVID-19.

Radiologists versus Deep Convolutional Neural Networks: A Comparative Study for Diagnosing COVID-19.

The reverse transcriptase polymerase chain reaction (RT-PCR) is still the routinely used test for the diagnosis of SARS-CoV-2 (COVID-19). However, according to several reports, RT-PCR showed a low sensitivity and multiple tests may be required to rule out false negative results. Recently, chest computed tomography (CT) has been an efficient tool to diagnose COVID-19 as it is directly affecting the lungs. In this paper, we investigate the application of pre-trained models in diagnosing patients who are positive for COVID-19 and differentiating it from normal patients, who tested negative for coronavirus. The study aims to compare the generalization capabilities of deep learning models with two thoracic radiologists in diagnosing COVID-19 chest CT images. A dataset of 3000 images was obtained from the Near East Hospital, Cyprus, and used to train and to test the three employed pre-trained models. In a test set of 250 images used to evaluate the deep neural networks and the radiologists, it was found that deep networks (ResNet-18, ResNet-50, and DenseNet-201) can outperform the radiologists in terms of higher accuracy (97.8%), sensitivity (98.1%), specificity (97.3%), precision (98.4%), and F1-score (198.25%), in classifying COVID-19 images.

Multilevel Deep-Aggregated Boosted Network to Recognize COVID-19 Infection from Large-Scale Heterogeneous Radiographic Data.

In the present epidemic of the coronavirus disease 2019 (COVID-19), radiological imaging modalities, such as X-ray and computed tomography (CT), have been identified as effective diagnostic tools. However, the subjective assessment of radiographic examination is a time-consuming task and demands expert radiologists. Recent advancements in artificial intelligence have enhanced the diagnostic power of computer-aided diagnosis (CAD) tools and assisted medical specialists in making efficient diagnostic decisions. In this work, we propose an optimal multilevel deep-aggregated boosted network to recognize COVID-19 infection from heterogeneous radiographic data, including X-ray and CT images. Our method leverages multilevel deep-aggregated features and multistage training via a mutually beneficial approach to maximize the overall CAD performance. To improve the interpretation of CAD predictions, these multilevel deep features are visualized as additional outputs that can assist radiologists in validating the CAD results. A total of six publicly available datasets were fused to build a single large-scale heterogeneous radiographic collection that was used to analyze the performance of the proposed technique and other baseline methods. To preserve generality of our method, we selected different patient data for training, validation, and testing, and consequently, the data of same patient were not included in training, validation, and testing subsets. In addition, fivefold cross-validation was performed in all the experiments for a fair evaluation. Our method exhibits promising performance values of 95.38%, 95.57%, 92.53%, 98.14%, 93.16%, and 98.55% in terms of average accuracy, F-measure, specificity, sensitivity, precision, and area under the curve, respectively and outperforms various state-of-the-art methods.

Machine learning is the key to diagnose COVID-19: a proof-of-concept study.

The reverse transcription-polymerase chain reaction (RT-PCR) assay is the accepted standard for coronavirus disease 2019 (COVID-19) diagnosis. As any test, RT-PCR provides false negative results that can be rectified by clinicians by confronting clinical, biological and imaging data. The combination of RT-PCR and chest-CT could improve diagnosis performance, but this would requires considerable resources for its rapid use in all patients with suspected COVID-19. The potential contribution of machine learning in this situation has not been fully evaluated. The objective of this study was to develop and evaluate machine learning models using routine clinical and laboratory data to improve the performance of RT-PCR and chest-CT for COVID-19 diagnosis among post-emergency hospitalized patients. All adults admitted to the ED for suspected COVID-19, and then hospitalized at Rennes academic hospital, France, between March 20, 2020 and May 5, 2020 were included in the study. Three model types were created: logistic regression, random forest, and neural network. Each model was trained to diagnose COVID-19 using different sets of variables. Area under the receiving operator characteristics curve (AUC) was the primary outcome to evaluate model's performances. 536 patients were included in the study: 106 in the COVID group, 430 in the NOT-COVID group. The AUC values of chest-CT and RT-PCR increased from 0.778 to 0.892 and from 0.852 to 0.930, respectively, with the contribution of machine learning. After generalization, machine learning models will allow increasing chest-CT and RT-PCR performances for COVID-19 diagnosis.

PSSPNN: PatchShuffle Stochastic Pooling Neural Network for an Explainable Diagnosis of COVID-19 with Multiple-Way Data Augmentation.

AIM: COVID-19 has caused large death tolls all over the world. Accurate diagnosis is of significant importance for early treatment. METHODS: In this study, we proposed a novel PSSPNN model for classification between COVID-19, secondary pulmonary tuberculosis, community-captured pneumonia, and healthy subjects. PSSPNN entails five improvements: we first proposed the n-conv stochastic pooling module. Second, a novel stochastic pooling neural network was proposed. Third, PatchShuffle was introduced as a regularization term. Fourth, an improved multiple-way data augmentation was used. Fifth, Grad-CAM was utilized to interpret our AI model. RESULTS: The 10 runs with random seed on the test set showed our algorithm achieved a microaveraged F1 score of 95.79%. Moreover, our method is better than nine state-of-the-art approaches. CONCLUSION: This proposed PSSPNN will help assist radiologists to make diagnosis more quickly and accurately on COVID-19 cases.